A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.
Aveanna Healthcare Holdings Inc. AVAH
Weak (graded 2026-07-21, not re-checked) broader-coverage candidate · Aveanna Healthcare Holdings Inc.
On FrontierLab's discovery record since 2026-06-12 (10 weeks ago) — when this name first surfaced. (distinct from the snapshot date below)
Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Weak" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-07-21), not the curated Frontier signal.
Key quality signals
| Revenue growth (YoY) | 20.5% |
|---|---|
| Gross margin | 32.7% |
| Gross profits / assets | 0.41 |
| Rule of 40 | 32 |
| Net margin | 11.5% |
| Cash runway (months) | — |
| PEG | — |
| Price / sales | 0.8 |
Quality checklist
- ✓ Revenue growth — 20.5% (pass ≥ 20%)
- ✓ Gross profits / assets — 0.41 (pass ≥ 0.33)
- ✗ Gross margin — 32.7% (pass ≥ 60%)
- ✓ Cash generation
- ✗ Share dilution — 7.7%
Fundamentals — snapshot as of 2026-07-21
| Stage | Established |
|---|---|
| Share issuance (YoY) | 7.7% · heavy issuance |
| Moat | — |
| TAM | — |
| P/E (trailing) | 8 |
| EPS (trailing) | $1.21 |
| Burn multiple | — |
| Gross-margin trend (pts) | 0.5 |
| Cash / assets | 0.09 |
| Net debt / EBITDA | 4.4 |
| Statements as of | Q1 FY2026 · filed 2026-05-14 |
Momentum context — a snapshot from 2026-07-21, not current
| Price at surface | $9.69 (as of 2026-07-21) |
|---|---|
| 52-week range | $3.73 – $10.32 |
| % off 52-wk high | -6.1% |
| RSI (14) | 69 |
| Relative volume | 0.8× |
Risk flags
← All broader-coverage names · Curated names → · Open the interactive screener →
Data as of 2026-07-21 (end-of-day). How grades are computed →